[1] | Sakamoto K., 2004, Radiobiological bases for cancer therapy by total or half-body irradiation., Nonlinearity in Biology, Toxicology, and Medicine., 2, 293–316. doi: 10.1080/15401420490900254. |
[2] | Hosoi Y., 2006, Antitumor effects by low dose total body irradiation., YAKUGAKU ZASSHI, 126, 841-848. doi: http://doi.org/10.1248/yakushi.126.841. |
[3] | Shoutko A. and Shatinina N., 1998, Chronic cancer - could it be?, Coherence-Int J of Integrative Medicine, 2, 36-40. www.iaam.nl/coherence/msaima/298-3.HTML. |
[4] | A. N. Shoutko, L. P. Ekimova, M. .J. Vasilyeva, and N. N. Shatinina “Tissue factors involved in cancer induction” in: J. Peter, G. Schnider, A. Bayer, editors. “High level of natural radiation and radon areas: radiation dose and health effects”, 2002, Part 2, Bundesamt fur Strahlenscutz Schriften. Proc. of 5th international conference on high levels of natural radiation and radon areas held in Munich, Germany on September 4 to 7 March 2000., pp. 467– 470. |
[5] | Shoutko A. and Yurkova L., 2001, Indirect control of tumor growth in radiotherapy., Coherence-Int J of Integrative Medicine, 2, 36-40.www.iaam.nl/coherence/coherence0001.htm –. |
[6] | de Leeuw R. J., Kost S. E., Kakal J. A., and Nelson BH., 2012, The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature.., Clinical Cancer Research, 18(11), 3022-3029. doi: 10.1158/1078-0432.CCR-11-32. |
[7] | Ray-Coquard I., Cropet C., Van Glabbeke M., Sebban C., Le Cesne A., Judson I. et al., 2009, Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas., Cancer Res., 69(13), 5383–5391. doi:10.1158/0008-5472.CAN-08-3845. |
[8] | Propert K. J. and Anderson J. R., 1988, Assessing the effect of toxicity on prognosis: methods of analysis and interpretation., JCO, 6, 868-870.http://jco.ascopubs.org/content/6/5/868.full.pdf. |
[9] | Tewari K. S., Java J. J., Gatcliffe T. A., Bookman M. A., and Monk B. J., 2014, Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: an exploratory study of the gynecologic oncology group., Gynecol. Oncol., 133(3), 439-445. PMID:24657300; doi:10.1016/j.ygyno..03.013. |
[10] | Su Z., Mao Y.-P., Ou Yang P.-Y., Tang J., Lan X..-W., and Xie F.-Y., 2015, Leucopenia and treatment efficacy in advanced nasopharyngeal carcinoma., BMC Cancer, 15, 429. doi:10.1186/s12885-015-1442-3. |
[11] | Shoutko A. N., Yurkova L. E., Borodulya K. S., and Ekimova L. P., 2015, Lymphocytopenia and cytotoxic therapy in patients with advanced ovarian cancer., Cancer Research Journal, 3(3), 47-51. doi: 10.11648/j.crj.20150303.11. |
[12] | Kucia M., Ratajczak J., and Ratajczak M. Z., 2005, Bone marrow as a source of circulating CXCR4+ tissue committed stem cells., Biol Cell, 97, 133–146. doi:10.1042/BC20040069. |
[13] | Ch. Drapeau Cracking the stem cell code: demystifying the most dramatic scientific breakthrough of our times. 1st. ed., Hillsboro, Or, USA; Goodwill Books, Sutton Hart Press, 2010.http://www.amazon.com/Cracking-Stem-Cell-Code-Miraculous/dp/098102095X. |
[14] | Hur J., Yang H.-M., Yoon C.-H., Lee C.-S., Park K.-W., Kim J.-H. et al., 2007, Identification of a novel role of T cells in postnatal vasculogenesis. Characterization of endothelial progenitor cell colonies., Circulation, 116(15), 1671-1682. PMID:17909106. |
[15] | Oakley P. A., 2015, Is use of radiation hormesis the missing link to a better cancer treatment?, Journal of Cancer Therapy, 6, 601-605. http://dx.doi.org/10.4236/jct.2015.67065. |
[16] | Shoutko A. N. and Ekimova L. P., 2014, Abnormal tissue proliferation and life span variability in chronically irradiated dogs., Radiat. Environ. Biophys., 53 (1), 65-72. |
[17] | Shoutko A., Ekimova L., Mus V., and Sokurenko V., 2012, Fluctuations of CD34 cells number in blood of cancer patients during final year of life., Medical and Health Science Journal (MHSJ)/Acad. Publ. Platform, 13(4), 7–13. academicpublishingplatforms.com/article.php?. |
[18] | Shutko A. N., Akushevich I. V., Ekimova L. P., Mus V. F., Sokurenko V. P., Yurkova L. E. et al., 2013, The mechanism of the antitumor effect of total/subtotal radiotherapy with non-tumoricidal doses of radiation., Voprosy onkologii, 59(4), 475-478. PMID 24032222. |
[19] | Shoutko A. N. and Ekimova L. P., 2014, Lymphocytopenia can contribute in common benefit of cytotoxic therapy of cancer., Inter-Medical, 3, 5-13.www.intermedical.ru/zhurnaly/17-zhurnal-1/meditsinskienauki; http://inter-medical.ru/files/Arhiv/26-27.09.2014/inter3.pdf. |
[20] | Shoutko A. N. and Ekimova L. P., 2014, The impact of middle age on the viability of patients with nonmalignant and malignant diseases., Cancer Research Journal, 2(6), 114-120. doi: 10.11648/j.crj.20140206.1. |
[21] | Calvert AH, Newell DR, Gumbrell LA, Reilly SO, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME, and Wiltshaw E., 1989, Carboplatin dosage: prospective evaluation of a simple formula based on renal function., J. Clin. Oncol., 7, 1748-1756. |
[22] | W. Nothdurft “Bone Marrow” in: E. Scherer, C. Streffer, and K. Trott, editors. ”Radiopathology of organs and tissues”, Berlin, Germany; Springer-Verlag, 1991. pp. 113-169. https://books.google.ru/books?isbn. |
[23] | L. Lee Jonson and J. H. Shih “An introduction to survival analysis (Chapter 20)” in: J. I. Gallin, F. P. Ognibene, editors. “Principles and practice of clinical research”, 2-nd ed. Amsterdam, N-Y, Elsevier AP, Academic Press, 2007. pp.273-282. |
[24] | Zaman Q. and Pfeiffer K. P., 2012, Does log-rank test give satisfactory results?, Journal of Applied Quantitative Methods (JAQM), 7 (1), 3–8. ICID: 1076992 journals.indexcopernicus.com/issue.php?id. |
[25] | U.S. Department of Health and Human Services, National Institute of Health, National Cancer Institute. “Blood/bone marrow” in “Common terminology criteria for adverse events” (CTCAE)/Version 3.0, AMGEN Oncology; August 2006. p.4. ctep.cancer.gov/.../electronic.../ctcaev3.pdf. |
[26] | J. L. Loveland “Mathematical justification of introductory hypothesis tests and development of reference materials” (M.Sc. (Mathematics). Utah State University, 2011, April 2013.http://digitalcommons.usu.edu/cgi/viewcontent.cgi?article=1014&context=gradreports. |
[27] | J. H. Heinzerling, J. Cho, and H. Choy “The role of radiotherapy in the treatment of metastatic diseases” in D. Lyden,.D.R. Welch, B. Psaila, editords. “Cancer metastasis: biologic basis and therapeutics”. New York, USA; Cambrige University Press, 2011. pp. 612-621 https://books.google.ru/books?isbn... |
[28] | Fliedner T. M. and Graessle D.H., 2012, Hemopoietic response to low dose-rates of ionizing radiation shows stem cell tolerance and adaptation., Dose Response, 10 (4),644-663. doi: 10.2203/dose-response.12-014.Feinendegen. |
[29] | Shoutko A. N., Ekimova L. P., Sokurenko V. P., Matyurin K. C., and Karamullin M.A., 2011, Alternative changes of lymphocytopoiesis of cancer patients are retained during radiation therapy., Proc. 14th International Congress of Radiation Research (ICRR2011) held 28 August - 1 September 2011, Warszawa, Poland, 163. www.proceedings.com/16135.html. |
[30] | M. Akiyama and Y. Kusunoki “Immune function” in I. Shigematsu, C. Ito, N. Kamada, M. Akiyama, H. Sasaki, B. Harrison, editors. “Effects of A-bomb radiation on the human body”. Tokyo, Japan; Harwood academic publishers, Bunkodo Co., 1995. pp. 290-306. |
[31] | G. Beretta Cancer chemotherapy regimens. Milano, Italy; Farmitalia Carlo Erba; 1983. opac.sbn.it/.../opaclib. |
[32] | J. L. Liesveld, Ph. Rubin, and L. S. Constine. “Hematopoietic system” in: Ph. Rubin, L/S/ Constine, L.B. Marks, editors. “Adverse late effects of cancer treatment. v.2: Normal tissue specific sites and systems”, Heidelberg, Germany; Springer Verlag; 2014. pp. 623-656. doi: 10.1007/978-3-540-75863-1. |
[33] | Shuryak I., Hahnfeldt Ph., Hlatky L., Suchs R. K., and Brenner D. J., 2009, A new view of radiation induced cancer: integrating short- and long-term processes. Part II: Second cancer risk estimation., Radiat. Environ. Biophys., Aug; 48 (3), 275–286. |
[34] | Kopjar N., Garaj-Vrhovac V., Kasuba V., Rozgaj R., Ramiċ S., Pavlica V. et al., 2009, Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drugs: a multi-biomarker approach., Int. J. Hyg. Environ. Health, 212 (4), 414–431. |
[35] | T. Szepesi, J. Naude, and B. Schnider. “Blood cell changes as indicators of reversible and irreversible haemotopoietic damage to the stem cell pool” in “The hemopoietic stem cell”, Ulm, Germany; Universitet Ulm GmbH; 1989. pp.113-132. |
[36] | Song Ch. W., Lee Y.-J., Griffin R. J., Park I., Koonce N. A., Hui S. et al., 2015, Indirect tumor cell death after highdose hypofractionated irradiation: implications for stereotactic body radiation therapy and stereotactic radiation surgery., Int J Radiation Oncol Biol Phys., 93(1), 166–172. doi:http://www.redjournal.org/issue/S0360-3016(15)X0010-1. |
[37] | Shoutko A. N., Gerasimova O. A., Ekimova L. P., Zherebtsov F. K., Mus V. F., Granov D. A. et al., 2016, Long –term activation of circulating liver-committed mononuclear cells after OLT., J J Regener Med.,. 2(1), 011. http://regenerativemedicine.jacobspublishers.com/images/Regenarative/J_J_Regener_Med_2_1_011.pdf. |
[38] | Cohen B. L., 1995, Test of the linear-no threshold theory of radiation carcinogenesis for inhaled radon decay products., Health Physics, 68, 157-174. |
[39] | Luckey T. D., 2008, Radiation prevents much cancer., International Journal of Low Radiation, 4 (4), 336-344. |
[40] | Nair R. R., Rajan B., Akiba S., Jayalekshmi P., Nair M. K., Gangadharan P., et al., 2009, Background radiation and cancer incidence in Kerala, India-Karanagappally cohort study., Health physics, 96(1),55-66.doi: 10.1097/01.HP.0000327646.54923.11. |
[41] | Scott B. R., 2008, Low-dose-radiation stimulated natural chemical and biological protection against lung cancer., Dose Response,. 6 (3), 299–318. |
[42] | Scott B. R., 2014, Radiation-hormesis phenotypes, the related mechanisms and implications for disease prevention and therapy., J Cell Commun Signal., 8 (4), 341–352. doi: 10.1007/s12079-014-0250-xPMCID: PMC4390804. |
[43] | Kashcheev V. V., Chekin S. Yu., Maksioutov M. A., Tumanov K. A., Kochergina E. V., Kashcheeva P. V. et al., 2015, Incidence and mortality of solid cancer among emergency workers of the Chernobyl accident: assessment of radiation risks for the follow-up period of 1992–2009., Radiat. Environ. Biophys., 54 (1),13-23. |